Vaccines' Slippery Slope
•
July 19, 2010 11:30 AM
As I’ve written about the medical and pharmaceutical’s industry of death and creation of vaccines from aborted babies, I’ve observed a tangled web that’s arisen over our nation. With a monopoly on vaccines, the traditional pharmaceutical companies aren’t exactly threatened by those desiring to make ethical alternative vaccines, but a current case in the court is trying to change that.
As the founder of two pro-life medical companies, Dr. Theresa Deisher is trying to develop pro-life vaccines and other ethical research. Deisher who founded, AVM Biotechnology and Sound Choice Pharmaceutical Institute (SCPI), has a reputable and impressive history in cellular research. In part, these companies were founded because “the use of aborted fetal tissue and embryonic cells in the discovery, development, and production of vaccines and pharmaceuticals has increased dramatically in the past decade” (AVM).
When it comes to vaccines, there’s been a surge in development of alternatives in recent years. SCPI, AVM’s counterpart pharmaceutical company, exists to develop safe medicines that are also morally pure. According to the website:
Over the past decade the use of aborted fetal material has slowly, almost imperceptibly, seeped into and become routine at many stages of drug discovery, development and commercialization, to the point where aborted fetal material is now being used to discover new food additives and flavor enhancers. (Source)
